Marking the end of BMW’s legendary V12 era, the M760i remains a rare and powerful masterpiece that blends brute force with ...

BMW is currently the luxury segment leader. The 750e has the most technology, the most performance and the most space. It’s ...

RE7 director Koshi Nakanishi is leading the project, hinting at a return of some of its designs, like the experimental Ethan Must Die mode from the Banned Footage DLC. Capcom could combine ...

With its pricing still under wraps, the BYD Sealion 7 offers an impressive overall package, but is it a better choice than the BMW iX1 LWB? Let’s find out After being showcased at the Auto Expo ...

Learn more. AUBURN — Community Little Theater is presenting the second show of its 85th season, the musical “Nunsense.” It is set for 7:30 p.m. Friday and Saturday, March 7-8; and Thursday ...

Chattanooga State Theatre Department to present the musical ... be in the Humanities Auditorium at Chattanooga State from March 7-9, 2025. Kara Mullins and Valerie Duke were on the show today ...

Does it work between a 1 and 3 Series? If you’ve considered the BMW 2 Series Gran Coupe a niche ... enabling a 0-62mph time of 7.9 seconds and a 143mph top speed. If you want a bit more power ...

This now encompasses more of the case’s right edge, shown above, rather than around the ‘Start/Stop’ button on the Fenix 7 series. We don’t suspect this will be a dealbreaker for most ...

which suggests BMW is serious. There’s a reworked double kidney grille, newly available with an illuminated LED surround, as seen on the 5 and 7 Series. The grille is finished in black and gives ...

They also feature a gaming mode, though I’m a bit surprised by the description: “Gaming Mode can be activated via the Final Connect app and will instantly achieve a low latency connection of ...

The U.S. Army 7th Signal Command (Theater) held a change of responsibility ceremony at the Defense Information School (DINFOS) at Fort George G. Meade, Maryland Thursday, February 27. Command Sgt.

Eikon Therapeutics is no stranger to eye-popping funding rounds, and the cancer-focused biotech has continued this trend with a $350.7 million series D to fuel its various clinical trials.